Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Aug 7, 2026
Reporting period
Not applicable
Filed with the SEC
Aug 11, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references dividend reinvestment
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000318154-26-000131
Filed / recorded
Aug 11, 2026, 12:20 AM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
AMGEN INC
Issuer CIK
318154
Ticker
AMGN
Reporting person
Michael V Drake
Relationship
Director
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Aug 7, 2026
Transaction code
A
Shares / units
63.8764
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
5,876.1633
Ownership form
Direct
Amendment
No
Footnotes from the filing
These shares include 377 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Around the same time
David J. Taylor soldRepublican, Representative, OH district 2R · OH-2
David J. Taylor soldRepublican, Representative, OH district 2
Sheldon Whitehouse soldDemocrat, Senator, RISits on Senate Finance, Health Care